STOCK TITAN

Hims & Hers Health, Inc. - HIMS STOCK NEWS

Welcome to our dedicated page for Hims & Hers Health news (Ticker: HIMS), a resource for investors and traders seeking the latest updates and insights on Hims & Hers Health stock.

Hims & Hers Health, Inc. (HIMS) is a cutting-edge telehealth company, headquartered in San Francisco, California, that revolutionizes the way people access healthcare. Founded in 2013, the company provides a multi-specialty platform connecting consumers to licensed healthcare professionals, offering a seamless path to high-quality medical care for various conditions.

Hims & Hers Health, Inc. specializes in a broad range of wellness products and services. Their portfolio includes treatments for hair loss, sexual wellness products, skincare lines, and oral care solutions. The company also diversifies its offerings through an exclusive range of men's fashion items including sweaters, jackets, corduroy, sport coats, wool overcoats, leather boots, flannel shirts, caps, and candles. All products are conveniently available for purchase through their online platform.

The telehealth services provided by Hims & Hers are comprehensive, covering mental health, sexual health, dermatology, primary care, and more. This robust platform ensures consumers receive professional medical consultations from the comfort of their homes.

Hims & Hers Health, Inc. continues to innovate and expand its services to meet the evolving needs of its customers. Recent achievements include advancements in their telehealth technology, expanding partnerships with renowned medical professionals, and enhancing their product lines. The company is financially sound and continues to grow, reflecting positive market performance and consumer trust.

For the latest updates, financial reports, and company news, Hims & Hers Health remains a significant player in both the wellness product market and the telehealth industry.

Rhea-AI Summary

Hims & Hers Health, Inc. (NYSE: HIMS) appointed Dr. Scott Knoer as its first Chief Pharmacy & Innovation Officer, focusing on pharmacy strategy and innovation. With over two decades of experience, Knoer previously served as the Chief Pharmacy Officer at Cleveland Clinic and CEO of the American Pharmacists Association. Hims & Hers reported strong Q3 2022 results with a 95% revenue increase to $144.8 million and 170,000 new subscriptions, bringing total subscriptions to 991,000. The company is expanding its pharmacy operations with new facilities in Ohio and Arizona.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.51%
Tags
management
-
Rhea-AI Summary

Hims & Hers Health, Inc. has partnered with ChristianaCare to enhance healthcare access, expanding its network to 10 states and Washington D.C. This collaboration will facilitate patient referrals for complex conditions, integrating ChristianaCare's Center for Virtual Health with Hims & Hers' platform. This move aligns with Hims & Hers' mission of providing high-quality, affordable care, benefiting consumers in Delaware, Maryland, New Jersey, and Pennsylvania. The partnership enhances service offerings, making healthcare more convenient and accessible.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.41%
Tags
partnership
-
Rhea-AI Summary

Hims & Hers Health reported a strong Q3 2022 with a revenue of $144.8 million, up 95% year-over-year. The company gained over 170,000 net new subscriptions, totaling 991,000 subscriptions, representing an 80% increase year-over-year. Hims & Hers raised its 2022 revenue guidance to $519-$522 million and expects Adjusted EBITDA of $(20) million to $(18) million. Despite a net loss of $(18.8) million, the company aims for Adjusted EBITDA profitability in Q4 2022, citing operational leverage and consumer adoption.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.7%
Tags
Rhea-AI Summary

Hims & Hers Health, Inc. (NYSE: HIMS) will report its third quarter 2022 financial results after the market closes on November 7, 2022. A conference call to discuss the results will be held at 5:00 p.m. ET, accessible via U.S. dialing at (888) 510-2630 and internationally at (646) 960-0137, with conference ID 1704296. Hims & Hers is a consumer-first health platform offering treatments for various conditions, connecting patients with healthcare professionals for prescription fulfillment through a subscription model.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.15%
Tags
-
Rhea-AI Summary

Hims & Hers Health, Inc. (NYSE: HIMS) has appointed Brian O’Shaughnessy as Chief Communications Officer and Josh Krueger as VP of Fulfillment Operations. O’Shaughnessy brings over two decades of experience from Google and Skype, where he led notable product communications. Krueger, formerly at Walmart and Amazon, has significant expertise in fulfillment operations. These hires aim to enhance Hims & Hers’ growth and improve customer experiences, following strong financial results with over $100 million in revenue and 100,000 new subscribers in Q2 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.32%
Tags
none
News
Rhea-AI Summary

Hims & Hers Health has launched its mobile apps on Android following a successful iOS rollout in Q1 2022. This expansion allows users to engage with the brand 3x more than before. The apps offer features such as subscription management, shipment tracking, and access to medical experts. They include innovative programs designed to improve consumer wellness. The company aims to enhance access to healthcare and wellness solutions, serving a broad range of health conditions through its platform.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.81%
Tags
none
-
Rhea-AI Summary

Hims & Hers Health reported Q2 2022 revenue of $113.6 million, marking an 87% year-over-year increase. The company achieved over 100k net new subscriptions, totaling 817,000, an 80% increase from the previous year. Hims & Hers raised its full-year 2022 revenue guidance to $470 million to $485 million, with an adjusted EBITDA forecast of $(27) million to $(20) million. The company anticipates adjusted EBITDA profitability within the next four quarters, driven by operational efficiencies and strong platform demand.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.1%
Tags
-
Rhea-AI Summary

Hims & Hers Health, Inc. will announce its second quarter 2022 financial results on August 8, 2022, at 4:15 p.m. E.T.. A conference call will follow at 5:00 p.m. E.T. Participants can join by dialing +1 (888) 510-2630 for U.S. callers or +1 (646) 960-0137 for international callers, with the conference ID #1704296. The call will also be available via a live audio webcast. Hims & Hers offers a multi-specialty telehealth platform and serves a variety of health needs, with operations in the U.S. and the U.K.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.51%
Tags
Rhea-AI Summary

Hims & Hers Health, Inc. has launched a new line of supplements, Hers Wellness Essentials, specifically designed for women. The six products target various health concerns, including general health, mental wellness, gut health, digestive health, skin health, and libido. Available at CVS Pharmacy and other online platforms, these gluten-free, non-GMO, and vegetarian supplements utilize effective, naturally occurring ingredients. This expansion signifies Hims & Hers' commitment to offering personalized wellness options tailored to women's unique health needs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.41%
Tags
none

FAQ

What is the current stock price of Hims & Hers Health (HIMS)?

The current stock price of Hims & Hers Health (HIMS) is $26.2 as of December 20, 2024.

What is the market cap of Hims & Hers Health (HIMS)?

The market cap of Hims & Hers Health (HIMS) is approximately 5.8B.

What does Hims & Hers Health, Inc. do?

Hims & Hers Health, Inc. is a telehealth company offering wellness products and connecting consumers to licensed healthcare professionals for various medical conditions.

Where is Hims & Hers Health, Inc. based?

The company is based in San Francisco, California.

When was Hims & Hers Health, Inc. founded?

The company was founded in 2013.

What types of products does Hims & Hers offer?

Hims & Hers offers hair loss prevention medicines, sexual wellness products, skincare products, oral care solutions, as well as men's fashion items like sweaters, jackets, and leather boots.

What medical services are available through Hims & Hers?

The company provides telehealth services covering mental health, sexual health, dermatology, primary care, and more.

How can I purchase products from Hims & Hers?

Products are available for purchase online through their platform.

How is Hims & Hers Health, Inc. performing financially?

Hims & Hers Health, Inc. is financially sound and continues to grow, reflecting positive market performance.

What recent achievements has Hims & Hers Health, Inc. made?

Recent achievements include advancements in telehealth technology, expanding partnerships with medical professionals, and enhancing product lines.

Does Hims & Hers collaborate with healthcare professionals?

Yes, Hims & Hers connects consumers with licensed healthcare professionals for consultations and medical care.

What makes Hims & Hers Health, Inc. unique?

Hims & Hers combines a broad range of wellness products with comprehensive telehealth services, enabling convenient access to high-quality medical care from home.

Hims & Hers Health, Inc.

NYSE:HIMS

HIMS Rankings

HIMS Stock Data

5.76B
184.42M
11.37%
65.88%
18.09%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
SAN FRANCISCO